List Of drugs 2014 FDA
Farxiga (dapagliflozin) Tablets
Date of Approval: January 8, 2014
Treatment for: Diabetes Type 2
TASIMELTION…FDA Approves Hetlioz: First Treatment for Non-24 Hour Sleep-Wake Disorder in Blind Individuals
Date of Approval: January 31, 2014
Company: Vanda Pharmaceuticals, Inc.
FDA Approves Vimizim to Treat Mucopolysaccharidosis Type IVA
Vimizim (elosufase alfa) is an enzyme replacement therapy for patients with Mucopolysaccharidosis Type IVA (Morquio A syndrome).
Company: BioMarin Pharmaceutical Inc.
Date of FDA Approval: February 14, 2014
Treatment for: Mucopolysaccharidosis Type IVA
Tivorbex (indomethacin); Iroko Pharmaceuticals; For the treatment of acute pain, Approved February of 2014
Imbruvica (ibrutinib); Pharmacyclics; For the treatment of chronic lymphocytic leukemia, Approved February 2014
Northera (droxidopa); Chelsea Therapeutics; For the treatment of neurogenic orthostatic hypotension, Approved February 2014http://newdrugapprovals.org/2013/10/10/chelsea-therapeutics-announces-fda-advisory-committee-to-review-northera/